In older adults with lumbar spinal stenosis and neurogenic claudication who have failed conservative therapy, how do the findings of the SOUND trial compare with the INSEMA trial regarding the effectiveness of interspinous process devices versus standard decompressive surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SOUND Trial vs INSEMA Trial Comparison

I cannot provide a direct comparison between the SOUND and INSEMA trials as neither trial is included in the evidence provided. The evidence consists primarily of 2014 guidelines on lumbar fusion for stenosis without spondylolisthesis, which do not reference these specific trials.

What the Available Evidence Shows

The provided guidelines 1 consistently recommend against interspinous process devices or fusion procedures for uncomplicated lumbar spinal stenosis (Grade B recommendation). Standard decompression surgery alone is the recommended surgical approach for patients with neurogenic claudication who have failed conservative therapy and have no evidence of instability or spondylolisthesis 1.

Key Guideline Recommendations:

  • Surgical decompression is recommended for symptomatic neurogenic claudication when patients elect surgery (Grade C, Level II/III evidence) 1

  • Lumbar fusion is NOT recommended in the absence of deformity or instability, as it has not been shown to improve outcomes compared to decompression alone (Grade B, Level IV evidence) 1

  • Patients with less extensive surgery tend to do better - minimal decompression procedures show better outcomes than extensive decompression with fusion 1

Supporting Research Context:

The systematic review evidence 2, 3 demonstrates that decompressive surgery (with or without fusion) shows better results than conservative treatment for pain, disability, and quality of life at 3-6 months through 2-4 years of follow-up. However, one meta-analysis 3 noted that interspinous devices (X-STOP) showed patient satisfaction at early time points but had higher complication rates throughout follow-up.

Critical Gap:

To answer your specific question about SOUND vs INSEMA trials, you would need the actual trial publications, which are not present in this evidence set. These trials likely compared interspinous spacer devices versus decompression surgery, but without their data, I cannot make trial-specific comparisons.

Common Pitfall:

The 2014 guidelines predate both SOUND and INSEMA trials. The guideline recommendation against interspinous devices was based on limited evidence at that time. More recent high-quality RCTs (SOUND and INSEMA) would supersede these older guideline recommendations if they provide Level I evidence on this specific comparison.

Related Questions

In a 71-year-old man with progressive low back pain and neurogenic claudication due to moderate lumbar spinal canal stenosis at L3‑L4, and minimal relief from acetaminophen, what is the best next treatment option for his pain?
What is the recommended management for lumbar spinal stenosis with neurogenic claudication that improves when sitting and worsens with standing?
What treatment options are recommended for a patient with acute right-sided low back pain and sciatica due to multilevel lumbar spondylotic changes, mild-to-moderate central canal stenosis at L4‑5 (left) and L5‑S1 (right), and associated disc bulges and facet arthrosis?
What are the recommended physical therapy exercises for an adult with grade‑1 lumbar anterolisthesis without neurological deficit?
Which exercises should be avoided for a patient with lumbar spinal stenosis?
In a patient with rapid atrial fibrillation and normal or mildly reduced left‑ventricular systolic function, without congestive heart failure, severe hypotension, or high‑grade atrioventricular block, when is verapamil indicated for ventricular rate control?
How should dysesthesia caused by glucagon-like peptide-1 (GLP-1) receptor agonist therapy be treated?
What are the treatment options for a patient with type 2 diabetes mellitus, stage 4 chronic kidney disease, emphysema with wheezing, and upper respiratory infection symptoms?
In early-stage, clinically node-negative breast cancer (tumors ≤3 cm), how do the SOUND trial and the INSEMA trial compare regarding the safety of omitting sentinel lymph node biopsy?
What is the appropriate azithromycin dosage (100 mg per 5 ml suspension) for a child weighing 17.24 kg?
How should a patient on atorvastatin with a triglyceride level of 278 mg/dL be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.